Lates News

Protara Therapeutics (TARA.US): The first quarter of 2025 financial report achieved a revenue of 0 US dollars, the same as the previous value; earnings per share were -0.29 US dollars, improved from the previous value of -0.97 US dollars, and the expected value was -0.48 US dollars.